Disfunción tiroidea en los pacientes con carcinoma de células renales avanzado en tratamiento con sunitinib: un problema multifactorial

Fuertes Zamorano, Nuria; De Miguel Novoa, María Paz; Díaz Pérez, José Ángel; Martín Rojas-Marcos, Patricia; Montañez Zorrilla, María Carmen; Molino González, Ángel.
Endocrinol. nutr. (Ed. impr.) ; 57(10): 486-491, dic. 2010. ilus, tab
Artículo en Español | IBECS (España) | ID: ibc-118286

Documentos relacionados

  1. Renal Cell Carcinoma in End-Stage Renal Disease: A Retrospective Study in Patients from Hungary.
  2. Adherence to a healthy sleep pattern and risk of urologic cancers: A large prospective cohort study.
  3. Renal cell carcinoma outcomes in end-stage renal disease: A 40-year study from two Japanese institutions.
  4. A comparison of analytic approaches for investigating the obesity paradox in kidney cancer.
  5. Biological Support to Obesity Paradox in Renal Cell Carcinoma: A Review.
  6. Investigating the prevalence of primary thyroid dysfunction in obese and overweight individuals: Tehran thyroid study.
  7. [Treatment and prognosis of multiple primary malignant neoplasms complicated with renal cell carcinoma].
  8. Incidence, risk factors, and significance of 20% decrease from new baseline estimated glomerular filtration rate after radical and partial nephrectomy within 2 years.
  9. Clinical phenotype and genetic function analysis of a rare family with hereditary leiomyomatosis and renal cell carcinoma complicated with Birt-Hogg-Dubé syndrome.
  10. Clinical Study on Systemic Lupus Erythematosus Complicated with Knee Bone Infarction.